182 related articles for article (PubMed ID: 28291561)
1. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea.
Solano-Iturri G; García-Jiménez N; Solano-Iturri JD; Blanco-Sampascual S
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):71-72. PubMed ID: 28291561
[No Abstract] [Full Text] [Related]
2. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
[TBL] [Abstract][Full Text] [Related]
3. [Enteropathy by olmesartan].
Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
[No Abstract] [Full Text] [Related]
4. [Enteropathy associated with chronic use of olmesartan].
Téllez A; Pellicé M; Llobell A; Milisenda JC
Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
[No Abstract] [Full Text] [Related]
5. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
[No Abstract] [Full Text] [Related]
6. In brief: Olmesartan and sprue-like enteropathy.
Med Lett Drugs Ther; 2018 Jan; 60(1539):24. PubMed ID: 29364200
[No Abstract] [Full Text] [Related]
7. Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response.
Alonso-Beato R; González-Pérez JA; Demelo-Rodríguez P
Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):220-222. PubMed ID: 32192851
[No Abstract] [Full Text] [Related]
8. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
[TBL] [Abstract][Full Text] [Related]
9. A Clinical Approach to Chronic Diarrhea.
Dutra B; Siddiqui S; Everett J
Gastroenterology; 2022 Mar; 162(3):707-709. PubMed ID: 34331913
[No Abstract] [Full Text] [Related]
10. Liver injury related to olmesartan-associated sprue-like enteropathy.
Kogachi S; Treyzon L; Waters K; Sundaram V
Liver Int; 2019 Nov; 39(11):2204. PubMed ID: 31423708
[No Abstract] [Full Text] [Related]
11. Gastrointestinal: Olmesartan-induced enteropathy.
Shahzad MA; Harding D; Ruszkiewicz A; Tran E; England G; Philpott H
J Gastroenterol Hepatol; 2018 Oct; 33(10):1691. PubMed ID: 29968297
[No Abstract] [Full Text] [Related]
12. Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
Cook DR
Intern Med J; 2020 Jan; 50(1):130-132. PubMed ID: 31943610
[No Abstract] [Full Text] [Related]
13. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
[No Abstract] [Full Text] [Related]
14. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
[TBL] [Abstract][Full Text] [Related]
15. Olmesartan-induced enteropathy treated with budesonide.
Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
Choi EY; McKenna BJ
Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
[TBL] [Abstract][Full Text] [Related]
17. Chronic diarrhea and deep vein thrombosis during treatment with olmesartan.
Gião Antunes A; Vaz AM; Cadillá J; Peixe B; Guerreiro H
Rev Gastroenterol Mex (Engl Ed); 2018; 83(2):200-202. PubMed ID: 28676194
[No Abstract] [Full Text] [Related]
18. [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].
Rommel KP; Schneider E; Witschel I; Halm U; Zachäus M
Internist (Berl); 2018 Sep; 59(9):961-966. PubMed ID: 29637237
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level.
Rovira-Illamola M; Pagès-Puigdemont N; Sotoca-Momblona JM; Mensa-Vendrell M; Barba-Ávila O; Casasayas-Guilera M
Int J Clin Pharm; 2020 Apr; 42(2):737-743. PubMed ID: 32078107
[TBL] [Abstract][Full Text] [Related]
20. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
